1
Han Cheng Zhang, Bruce E Maryanoff, Hong Ye, Bruce R Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, Gabriel Lopez, Hal B Woodrow, January 17, 2006: US06987110 (44 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


2
Han Cheng Zhang, Gee Hong Kuo, Bruce E Maryanoff, Hong Ye, David O Neill, Lan Shen, Keith Demarest, Bruce R Conway, David F McComsey: Substituted pyrroline kinase inhibitors. Janssen Pharmaceutica, Yurity Stercho, October 24, 2006: US07125878 (15 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.


3

4
Han Cheng Zhang, Gee Hong Kuo, Bruce E Maryanoff, Hong Ye, David O Neill, Lan Shen, Keith Demarest, Bruce R Conway, David F McComsey: Substituted pyrroline kinase inhibitors. Janssen Pharmaceutica, Yurly P Stercho, August 24, 2010: US07781450 (1 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.


5
Han Cheng Zhang, Gee Hong Kuo, Bruce E Maryanoff, Hong Ye, David O Neill, Lan Shen, Keith Demarest, Bruce R Conway, David F McComsey: Substituted pyrroline kinase inhibitors. Janssen Pharmaceutica, Yuriy P Stercho, August 31, 2010: US07786135 (1 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.


6
Jacqueline C Bussolari, Xiaoli Chen, Bruce R Conway, Keith T Demarest, Hamish N M Ross, Rafael Severino: Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators. Ortho McNeil Pharmaceutical, October 2, 2012: US08278268

Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.


7
Jacqueline C Bussolari, Xiaoli Chen, Bruce R Conway, Keith T Demarest, Hamish N M Ross, Rafael Severino: Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators. Ortho McNeil Pharmaceutical, May 22, 2012: US08183213

Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.


8
Bruce R Conway, Hyo Chang Yun, Peter J Dutton, Thomas D Ratzlaff, Paul Craig Tally, James O Keeffe, Erling Hansen: Modular enclosure. TYCO ELECTRONICS CORPORATION, July 5, 2016: US09382038

An enclosure includes a plurality of modular corner segments and a plurality of modular wall segments that connect together to at least partially define an internal compartment of the enclosure. The wall segments extending lengths between opposite free ends. At least a majority of the wall segments ...


9
Bruce R Conway, Hyo Chang Yun, Peter J Dutton, Thomas D Ratzlaff, Paul Craig Tally, James O Keeffe, Erling Hansen: Modular enclosure. TYCO ELECTRONICS CORPORATION, July 12, 2016: US09392708

An enclosure includes a plurality of modular construction units that connect together to at least partially define an internal compartment of the enclosure. Each construction unit includes a wall segment extending a length from a corner end to a free end, and a corner segment extending outward from ...


10
Han Cheng Zhang, Bruce E Maryanoff, Hong Ye, Bruce R Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, March 25, 2004: US20040059113-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.